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+ regulatory T cells in mice via signals from sympathetic nervous system 
Introduction
Accumulating evidence suggests that regulatory T cells are key immunomodulators after ischemic stroke and may contribute to post-stroke immunosuppression and infectious complications, such as pneumonia (Chamorro et al., 2007; Dirnagl et al., 2007; Liesz et al., 2009; Meisel et al., 2005; Offner et al., 2006; Prass et al., 2003) . However, few studies have investigated the cellular and molecular mechanisms of ischemic stroke-induced immunosuppression.
It has recently become clear that peripheral tolerance and immune homeostasis are largely maintained by immunosuppressive regulatory T cells, such as CD4 -35 (Sakaguchi et al., 2008; Wing and Sakaguchi, 2010) . Evidence from clinical trials and from preclinical studies that used the middle cerebral artery occlusion (MCAO) model showed that stroke causes marked elevations in the number of Treg cells in peripheral blood and spleen (Offner et al., 2006; Yan et al., 2009 ). Treg cells decrease T cell activation and reduce production of interferon-c (c-IFN), one of the most important factors for preventing bacterial infections (Liesz et al., 2009; Liu et al., 2011; Mahic et al., 2006; Offner et al., 2006) . Therefore, Treg cells are thought to be strongly associated with stroke-induced immunosuppression (Offner et al., 2006 (Offner et al., , 2009 
